Print Friendly, PDF & Email

NCT/Study#

NCT04904276 /

O-FOSTA-901 (Forte)

Observational Study Of Fostamatinib As Second Line Therapy In Adult Patients With Immune Thrombocytopenia (ITP) And Insufficient Response To A Prior Therapy

DISEASE GROUP:

ITP

current phase:

N/A

STUDY STATUS:

Accepting Patients

Location:

Little Silver, NJ

For More information:

Call 201-518-3587